Home › Funds › Atreides Management, LP › ALAB

Atreides Management, LP position in ALAB

ASTERA LABS INC · Technology

Atreides Management, LP reported holding 1,216,795 shares of ALAB (ASTERA LABS INC) in its Q2 2026 13F filing — a position valued at US$587.7M, representing 4.53% of its reported portfolio and ranking #4 among its reported holdings. Atreides Management, LP has disclosed ALAB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.22M sh
Reported value held$587.74M
Portfolio Weight4.53%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Atreides Management, LP's ALAB position evolved

Atreides Management, LP first disclosed a stake in ALAB in Q1 2024 at 2,665,792 shares (US$197.8M). The position peaked in Q2 2026 at 1,216,795 shares, worth US$587.7M. Across 10 filings, Atreides Management, LP increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,216,795 shares valued at US$587.7M — a reduction of -2,148,992 shares quarter over quarter.. Notable position changes include a 153% increase in Q1 2025 (shares rose 52% over the following quarter), a 2497% increase in Q4 2025 (shares fell 34% over the following quarter), a 109% increase in Q1 2026 (shares rose 341% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.67M $197.78M New
Q2 2024 2.78M $168.00M Add
Q3 2024 1.00M $52.39M Reduce
Q4 2024 1.84M $243.26M Add
Q1 2025 4.65M $277.60M Add
Q2 2025 954.78K $86.33M Reduce
Q3 2025 62.05K $12.15M Reduce
Q4 2025 1.61M $268.04M Add
Q1 2026 3.37M $368.89M Add
Q2 2026 1.22M $587.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALAB and 13F data

ALAB (ASTERA LABS INC) is a Technology company. 103 other funds we track also report a position in ALAB — the largest reported positions include Fidelity Management & Research (FMR) (US$12.00B), Banque Cantonale Vaudoise (US$2.67B), VAN ECK ASSOCIATES CORP (US$1.08B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALAB

All ALAB fund holders →

FAQ

How long has Atreides Management, LP held ALAB?

Atreides Management, LP has disclosed ALAB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Atreides Management, LP's current position in ALAB?

As of Q2 2026, Atreides Management, LP holds 1.22M shares of ALAB (ASTERA LABS INC), valued at $587.74M, representing 4.53% of its reported portfolio and ranking #4.

Has Atreides Management, LP been buying or selling ALAB?

In the latest 13F filing (Q2 2026), Atreides Management, LP reduced its position in ALAB. The position peaked in Q2 2026 at 1.22M shares.

Which other funds hold ALAB?

Other major institutional holders of ALAB include Fidelity Management & Research (FMR), Banque Cantonale Vaudoise, VAN ECK ASSOCIATES CORP, among 103 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.